Literature DB >> 33606698

A prospective study to evaluate the accuracy of rapid diagnostic tests for diagnosis of human leptospirosis: Result from THAI-LEPTO AKI study.

Janejira Dinhuzen1,2,3, Umaporn Limothai1,2, Sasipha Tachaboon1,2, Panadda Krairojananan4, Bangon Laosatiankit5, Sakarin Boonprasong5, Nuttha Lumlertgul1,2,6, Sadudee Peerapornratana1,2,6,7, Nattachai Srisawat1,2,6,8,9,10.   

Abstract

BACKGROUND: Rapid diagnostic tests (RDTs) have become widely used in low-resource settings for leptospirosis diagnostic. This study aims to evaluate the diagnostic performance of the five commercially available RDTs to detect human IgM against Leptospira spp. in Thai population. METHODOLOGY/PRINCIPAL
FINDINGS: Ninety-nine serum samples from Leptospirosis suspicious patients were tested with five RDTs, including Medical Science Public Health, Leptocheck-WB, SD bioline, TRUSTline, and J.Mitra. The case definition was based on MAT, qPCR, and culture results. Diagnostic accuracy was determined based on the first day of enrollment in an overall analysis and stratified according to days post-onset of fever. The five RDTs had overall sensitivity ranging from 1.8% to 75% and specificity ranging from 52.3% to 97.7%. Leptocheck-WB had high sensitivity of 75.0%. The sensitivity of five RDTs increased on days 4-6 post-onset of fever, while the specificity of all tests remained relatively stable at different days post-onset of fever.
CONCLUSIONS/SIGNIFICANCE: The tested RDTs showed low sensitivity. Therefore, based on the present study, five commercially available RDTs might not be an appropriate test for acute leptospirosis screening in the Thai population.

Entities:  

Year:  2021        PMID: 33606698      PMCID: PMC7894855          DOI: 10.1371/journal.pntd.0009159

Source DB:  PubMed          Journal:  PLoS Negl Trop Dis        ISSN: 1935-2727


  22 in total

Review 1.  Rapid tests for diagnosis of leptospirosis: current tools and emerging technologies.

Authors:  Mathieu Picardeau; Eric Bertherat; Michel Jancloes; Andreas N Skouloudis; Kara Durski; Rudy A Hartskeerl
Journal:  Diagn Microbiol Infect Dis       Date:  2013-10-01       Impact factor: 2.803

2.  Isolation and Culture of Leptospira from Clinical and Environmental Samples.

Authors:  Cyrille Goarant; Dominique Girault; Roman Thibeaux; Marie-Estelle Soupé-Gilbert
Journal:  Methods Mol Biol       Date:  2020

Review 3.  Leptospirosis.

Authors:  Alan J A McBride; Daniel A Athanazio; Mitermayer G Reis; Albert I Ko
Journal:  Curr Opin Infect Dis       Date:  2005-10       Impact factor: 4.915

4.  Differentiation of pathogenic and saprophytic letospires. I. Growth at low temperatures.

Authors:  R C Johnson; V G Harris
Journal:  J Bacteriol       Date:  1967-07       Impact factor: 3.490

5.  Evaluation of the immunochromatographic (Leptocheck) test for detection of specific antibodies against leptospires.

Authors:  Daša Podgoršek; Tjaša Cerar; Mateja Logar; Gorazd Lešničar; Tatjana Remec; Zvonko Baklan; Emil Pal; Eva Ružić-Sabljić
Journal:  Wien Klin Wochenschr       Date:  2015-09-17       Impact factor: 1.704

6.  Leptospirosis diagnosis: competancy of various laboratory tests.

Authors:  Suman Veerappa Budihal; Khalid Perwez
Journal:  J Clin Diagn Res       Date:  2013-06-17

Review 7.  Pathology and pathogenesis of human leptospirosis: a commented review.

Authors:  Thales De Brito; Ana Maria Gonçalves da Silva; Patrícia Antonia Estima Abreu
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2018-05-28       Impact factor: 1.846

8.  A simple score to predict severe leptospirosis.

Authors:  Simon Smith; Brendan J Kennedy; Alexis Dermedgoglou; Suzanne S Poulgrain; Matthew P Paavola; Tarryn L Minto; Michael Luc; Yu-Hsuan Liu; Josh Hanson
Journal:  PLoS Negl Trop Dis       Date:  2019-02-13

9.  A quantitative PCR (TaqMan) assay for pathogenic Leptospira spp.

Authors:  Lee D Smythe; Ina L Smith; Greg A Smith; Michael F Dohnt; Meegan L Symonds; Leonie J Barnett; David B McKay
Journal:  BMC Infect Dis       Date:  2002-07-08       Impact factor: 3.090

10.  Evaluation of two immunodiagnostic tests for early rapid diagnosis of leptospirosis in Sri Lanka: a preliminary study.

Authors:  Egwin J Eugene; Shiroma M Handunnetti; Shalini A Wickramasinghe; Thilini L Kalugalage; Chathuraka Rodrigo; Hasith Wickremesinghe; Nandana Dikmadugoda; Pranitha Somaratne; H Janaka De Silva; Senaka Rajapakse
Journal:  BMC Infect Dis       Date:  2015-08-11       Impact factor: 3.090

View more
  2 in total

1.  Clinical evaluation of the BioFire Global Fever Panel for the identification of malaria, leptospirosis, chikungunya, and dengue from whole blood: a prospective, multicentre, cross-sectional diagnostic accuracy study.

Authors:  Yukari C Manabe; Joshua Betz; Olivia Jackson; Victor Asoala; Isabel Bazan; Paul W Blair; Aileen Chang; Sarunyou Chusri; John A Crump; Kimberly A Edgel; Dennis J Faix; Stefan Fernandez; Anne T Fox; Jose A Garcia; Max Grogl; Erin A Hansen; Vireak Heang; Stacey L House; Krisada Jongsakul; Michael B Kaburise; Chonticha Klungthong; Mohammed Lamorde; Andrew G Letizia; Ivette Lorenzana; Malen Luy; Vanance P Maro; Christopher N Mores; Christopher A Myers; Abraham R Oduro; Leda Parham; Abigail J Porzucek; Michael Prouty; David S Rabiger; Matthew P Rubach; Crystyan Siles; Maria Silva; Chinaka Ukachu; John N Waitumbi; Cynthia L Phillips; Brian W Jones
Journal:  Lancet Infect Dis       Date:  2022-06-15       Impact factor: 71.421

2.  Rapid and sensitive point-of-care detection of Leptospira by RPA-CRISPR/Cas12a targeting lipL32.

Authors:  Sirawit Jirawannaporn; Umaporn Limothai; Sasipha Tachaboon; Janejira Dinhuzen; Patcharakorn Kiatamornrak; Watchadaporn Chaisuriyong; Jom Bhumitrakul; Oraphan Mayuramart; Sunchai Payungporn; Nattachai Srisawat
Journal:  PLoS Negl Trop Dis       Date:  2022-01-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.